AD: New Knowledge About Type 2 Inflammation and Skin Barrier Deficiency
In this MEDtalk, Stephan Weidinger, Professor of Dermatology from Kiel, gives his perspective on the importance of Type 2 inflammation and skin barrier deficiency in the development and choice of treatment for patients with atopic dermatitis based on the knowledge of which cytokines are most important for the management of AD.
